Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.

Abstract:

:Xeroderma pigmentosum (XP) is a sun-sensitive, cancer-prone genetic disorder characterized by a defect in nucleotide excision repair. The human nucleotide excision repair and transcription gene ERCC2 is able to restore survival to normal levels after exposure to UV light in XP complementation group D cells. No enhancement of UV survival is seen in groups C, E, F, or G. XP-CS-2 cells are complemented by ERCC2, confirming the reassignment to group D of this combined XP/Cockayne's syndrome patient. Nucleotide sequence analysis of the ERCC2 cDNA from five XP group D cell strains [XP6BE(SV40), XP17PV, XP102LO, A31-27 (a HeLa/XP102LO hybrid), and XP-CS-2] revealed mutations predominantly affecting previously identified functional domains. The mutations include base substitutions resulting in amino acid substitutions, deletions due to splicing alterations, and defects in expression. XP6BE(SV40), XP17PV, XP102LO, and A31-27 all have one allele with an Arg683 to Trp substitution within the putative nuclear location signal. The genetic disorder trichothiodystrophy (which is not cancer-prone) can also result from mutations in the ERCC2 gene, some of which are the same as those found in XP-D. The various clinical presentations can be correlated with the particular mutations found in the ERCC2 locus.

journal_name

Cancer Res

journal_title

Cancer research

authors

Takayama K,Salazar EP,Lehmann A,Stefanini M,Thompson LH,Weber CA

subject

Has Abstract

pub_date

1995-12-01 00:00:00

pages

5656-63

issue

23

eissn

0008-5472

issn

1538-7445

journal_volume

55

pub_type

杂志文章
  • DNA amplification and tumorigenicity of the human melanoma cell line MeWo.

    abstract::Homogeneously staining regions (HSRs) were found in hypodiploid cells (40%) of a subline of the human melanoma cell line, MeWo, (MeWo-C) but were absent from the hypotetraploid cells (60%). Another subline (MeWo-B) was also shown to contain two populations of cells, 70% hypodiploid and 30% hypotetraploid. None of the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shtromas I,White BN,Holden JJ,Reimer DL,Roder JC

    更新日期:1985-02-01 00:00:00

  • Continuous infusion of high-dose 1-beta-D-arabinofuranosylcytosine: a phase I and pharmacological study.

    abstract::High doses of 1-beta-D-arabinofuranosylcytosine, administered as a continuous i.v. infusion, were evaluated in a Phase I trial in 14 patients with advanced solid tumors. 1-beta-D-Arabinofuranosylcytosine was given at 250 mg/sq m/h for infusions of 12 to 36 h. The mean steady state 1-beta-D-arabinofuranosylcytosine pla...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Spriggs DR,Robbins G,Takvorian T,Kufe DW

    更新日期:1985-08-01 00:00:00

  • Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancer.

    abstract::Twenty-seven patients with advanced cancer were entered in a phase I study of bolus i.v. 5-fluorouracil at a dose of 370 mg/m2/day for 5 days combined with a continuous i.v. infusion of (6S)-folinic acid for 5.5 days, starting 24 h in advance of the first 5-fluorouracil dose. The dose of (6S)-folinic acid was escalate...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Newman EM,Akman SA,Harrison JS,Leong LA,Margolin KA,Morgan RJ,Raschko JW,Somlo G,Ahn CW,Doroshow JH

    更新日期:1992-05-01 00:00:00

  • Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy.

    abstract::Preclinical and clinical development of agents that inhibit cell-cycle progression have brought an understanding of the feasibility of targeting various cell-cycle regulators in patients with cancer. Small molecule inhibitors targeting key proteins that participate in cell-cycle progression including the cyclin-depend...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-17-2782

    authors: Mills CC,Kolb EA,Sampson VB

    更新日期:2018-01-15 00:00:00

  • An Immune-Inflammation Gene Expression Signature in Prostate Tumors of Smokers.

    abstract::Smokers develop metastatic prostate cancer more frequently than nonsmokers, suggesting that a tobacco-derived factor is driving metastatic progression. To identify smoking-induced alterations in human prostate cancer, we analyzed gene and protein expression patterns in tumors collected from current, past, and never sm...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-3630

    authors: Prueitt RL,Wallace TA,Glynn SA,Yi M,Tang W,Luo J,Dorsey TH,Stagliano KE,Gillespie JW,Hudson RS,Terunuma A,Shoe JL,Haines DC,Yfantis HG,Han M,Martin DN,Jordan SV,Borin JF,Naslund MJ,Alexander RB,Stephens RM,Loffr

    更新日期:2016-03-01 00:00:00

  • Human carcinoembryonic antigen functions as a general inhibitor of anoikis.

    abstract::Human carcinoembryonic antigen (CEA), a widely used tumor marker, and CEACAM6 [formerly nonspecific cross-reacting antigen (NCA)] are up-regulated in many types of human cancers, whereas family member CEACAM1 [formerly biliary glycoprotein (BGP)] is usually down-regulated. Deregulated overexpression of CEA/CEACAM6 but...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ordoñez C,Screaton RA,Ilantzis C,Stanners CP

    更新日期:2000-07-01 00:00:00

  • Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.

    abstract::Two commonly occurring genetic aberrations of human prostate cancer [i.e., overexpression of a mitogenic polypeptide (fibroblast growth factor 8, isoform b or FGF8b) and loss of function of PTEN tumor suppressor] were recapitulated into a new combinatorial mouse model. This model harboring the Fgf8b transgene and hapl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-3440

    authors: Zhong C,Saribekyan G,Liao CP,Cohen MB,Roy-Burman P

    更新日期:2006-02-15 00:00:00

  • Human monocytes, but not dendritic cells derived from them, are defective in base excision repair and hypersensitive to methylating agents.

    abstract::Monocytes and dendritic cells are key players in the immune response. Because dendritic cells drive the tumor host defense, it is important that monocytes and dendritic cells survive cytotoxic tumor therapy. Although most of the anticancer drugs target DNA, the DNA repair capacity of monocytes and dendritic cells has ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-3712

    authors: Briegert M,Kaina B

    更新日期:2007-01-01 00:00:00

  • Fully automated three-dimensional tracking of cancer cells in collagen gels: determination of motility phenotypes at the cellular level.

    abstract::We developed a fully automated three-dimensional cell tracking system that quantified the effect of extracellular matrix components on the infiltration and migration of tumor cells. The three-dimensional trajectories of two highly invasive cell lines, the human HT-1080 fibrosarcoma and the human MDA-MB-231 adenocarcin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Demou ZN,McIntire LV

    更新日期:2002-09-15 00:00:00

  • Rapid release of intracellular galectin-3 from breast carcinoma cells by fetuin.

    abstract::Galectin-3, a beta-galactoside binding protein, plays a significant role in cell to extracellular matrix interactions. Despite its extracellular expression, the precise physiological mechanisms that trigger its release from the intracellular milieu have not been characterized. The present analyses were, therefore, don...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zhu WQ,Ochieng J

    更新日期:2001-03-01 00:00:00

  • Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor.

    abstract::Specific progesterone binding by cultured human breast carcinoma T47D, MCF-7, and ZR75-1 cells was decreased 25-40% by epidermal growth factor (EGF), with a 50% effective dose of 0.1 nM EGF. Studies with the soluble and particulate fractions prepared after homogenization of T47D cells grown in glass roller bottles rev...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sarup JC,Rao KV,Fox CF

    更新日期:1988-09-15 00:00:00

  • Blood flow and venous pH of tissue-isolated Walker 256 carcinoma during hyperglycemia.

    abstract::Hemodynamic (blood flow rate, hematocrit, hemoglobin concentration, and blood viscosity) and pH responses to glucose (6 g/kg, i.p.) injections were studied in ten Walker 256 carcinoma tumors (0.5-1.8 g) grown in the "tissue-isolated" tumor preparation. A maximum blood flow reduction of 57 +/- 19% (SD) occurred concurr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sevick EM,Jain RK

    更新日期:1988-03-01 00:00:00

  • Coordination of intratumoral immune reaction and human colorectal cancer recurrence.

    abstract::A role for the immune system in controlling the progression of solid tumors has been established in several mouse models. However, the effect of immune responses and tumor escape on patient prognosis in the context of human cancer is poorly understood. Here, we investigate the cellular and molecular parameters that co...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-2654

    authors: Camus M,Tosolini M,Mlecnik B,Pagès F,Kirilovsky A,Berger A,Costes A,Bindea G,Charoentong P,Bruneval P,Trajanoski Z,Fridman WH,Galon J

    更新日期:2009-03-15 00:00:00

  • Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How.

    abstract::Advocates bring unique and important viewpoints to the cancer research process, ensuring that scientific and medical advances are patient-centered and relevant. In this article, we discuss the benefits of engaging advocates in cancer research and underscore ways in which both the scientific and patient communities can...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-18-1600

    authors: Salamone JM,Lucas W,Brundage SB,Holloway JN,Stahl SM,Carbine NE,London M,Greenwood N,Goyes R,Chisholm DC,Price E,Carlin R,Winarsky S,Baker KB,Maues J,Shajahan-Haq AN

    更新日期:2018-10-15 00:00:00

  • Heterotopic urinary bladder with a communicating reservoir.

    abstract::A heterotopic bladder attached to an Ommaya reservoir was transplanted to the back of a syngeneic rat. Following transplantation, the mucosa underwent ischemic necrosis. However, it was rapidly reepithelialized in 2 weeks as a result of spreading of the epithelium originating from the ureterotrigonal region. By light ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Oyasu R,Manning DJ,Matsumoto M,Hopp ML

    更新日期:1976-07-01 00:00:00

  • Camptothecin resistance involving steps subsequent to the formation of protein-linked DNA breaks in human camptothecin-resistant KB cell lines.

    abstract::To identify mechanisms of camptothecin (CPT) resistance/toxicity, sublines from a human KB cell line were made resistant to CPT by continuous selection in increasing concentrations of CPT. Two CPT-resistant lines, 100 and 300, were 32- and 54-fold resistant to the growth-inhibitory properties of CPT compared to the KB...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Beidler DR,Chang JY,Zhou BS,Cheng YC

    更新日期:1996-01-15 00:00:00

  • Human rhabdosarcoma cell-induced aggregation of blood platelets.

    abstract::The ability of tumor cells shed into the circulation to cause adhesion and aggregation of blood platelets may be involved in successful metastasis of primary tumors. Rhabdosarcoma is a rare, early metastasizing tumor previously uncharacterized for ability to alter platelet function. It was found that human rhabdosarco...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Longenecker GL,Beyers BJ,Bowen RJ,King T

    更新日期:1989-01-01 00:00:00

  • Quantitative changes in adenosine deaminase isoenzymes in human colorectal adenocarcinomas.

    abstract::Several reports have suggested that a decrease or absence of adenosine deaminase complexing protein (ADCP) is consistently associated with cancer. However, in other studies, decreased as well as increased ADCP levels were found. In the present study, we investigated ADCP levels in 37 colorectal adenocarcinomas and cor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: ten Kate J,Wijnen JT,van der Goes RG,Quadt R,Griffioen G,Bosman FT,Khan PM

    更新日期:1984-10-01 00:00:00

  • Volume-activated chloride current is not related to P-glycoprotein overexpression.

    abstract::It has been suggested that P-glycoprotein (P-gp), an ATP-dependent transporter responsible for classical multidrug resistance, is also a volume-regulated chloride channel. We reexamined this hypothesis by use of whole-cell patch clamp recordings of three matched pairs of cell lines, which were either drug-sensitive or...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dong Y,Chen KG,Durán GE,Kouyama K,Chao AC,Sikic BI,Gollapudi SV,Gupta S,Gardner P

    更新日期:1994-10-01 00:00:00

  • Cytogenetic characterization of B-cell lymphomas from severe combined immunodeficiency disease mice given injections of lymphocytes from Epstein-Barr virus-positive donors.

    abstract::We analyzed the karyotype of 27 B-cell lymphomas of human origin that developed in mice with severe combined immunodeficiency disease following the injection of peripheral blood leukocytes from Epstein-Barr virus-seropositive donors. Three tumors had clonal abnormalities detected with conventional techniques, 2 had tr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Thangavelu M,Snyder L,Anastasi J,Le Beau MM,Kirven M,Picchio G,Mosier DE,Rowley JD

    更新日期:1992-09-01 00:00:00

  • DNA damage in liver, kidney, bone marrow, and spleen of rats and mice treated with commercial and purified aniline as determined by alkaline elution assay and sister chromatid exchange induction.

    abstract::Aniline of unknown purity has been reported to induce spleen hemangiosarcoma in rats. Aniline has been found to be negative in terms of mutagenicity in both bacteria and yeasts. We have found that both commercial (already rather pure) and repurified aniline are clearly positive to a similar extent in inducing DNA dama...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Parodi S,Pala M,Russo P,Zunino A,Balbi C,Albini A,Valerio F,Cimberle MR,Santi L

    更新日期:1982-06-01 00:00:00

  • Acid pH in tumors and its potential for therapeutic exploitation.

    abstract::Measurement of pH in tissue has shown that the microenvironment in tumors is generally more acidic than in normal tissues. Major mechanisms which lead to tumor acidity probably include the production of lactic acid and hydrolysis of ATP in hypoxic regions of tumors. Further reduction in pH may be achieved in some tumo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tannock IF,Rotin D

    更新日期:1989-08-15 00:00:00

  • Activity of the cytosolic isozyme of thymidine kinase in human primary lung tumors with reference to malignancy.

    abstract::Activity increase of the cytosolic isozyme of thymidine kinase (TK) in resected specimens of lung tumor patients would be a useful marker for tumor malignancy and prognosis. In 24 resected cases of malignant lung tumors, the whole enzyme extracts of the tumorous part of the specimens showed that the activities of TK, ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yusa T,Yamaguchi Y,Ohwada H,Hayashi Y,Kuroiwa N,Morita T,Asanagi M,Moriyama Y,Fujimura S

    更新日期:1988-09-01 00:00:00

  • Ultrasonically activated chemotherapeutic drug delivery in a rat model.

    abstract::Systemic delivery of anticancer agents is accompanied by many unwanted side effects that can be mitigated by encapsulation of antineoplastic agents. However, encapsulation necessitates a technique for controlled delivery to the cancerous tissue. We have developed a novel drug delivery system that releases drug from st...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nelson JL,Roeder BL,Carmen JC,Roloff F,Pitt WG

    更新日期:2002-12-15 00:00:00

  • Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells.

    abstract::Overexpression of interleukin 6, a downstream target of the GBX2 homeobox gene, has been linked to the progression of prostate cancer. The Janus kinase-signal transducers and activators of transcription signaling pathway transmits interleukin 6-mediated signals from cell surface receptors to the target genes in the nu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ni Z,Lou W,Leman ES,Gao AC

    更新日期:2000-03-01 00:00:00

  • An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomas.

    abstract::Monoclonal antibodies (mAbs) can mediate antitumor effects by indirect mechanisms involving antiangiogenesis and up-regulation of the cellular immune response rather than by direct tumor cell destruction. From mAbs raised by immunization of rats with transformed murine endothelial cells, a mAb (EOL4G8) was selected fo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Melero I,Gabari I,Corbí AL,Relloso M,Mazzolini G,Schmitz V,Rodriguez-Calvillo M,Tirapu I,Camafeita E,Albar JP,Prieto J

    更新日期:2002-06-01 00:00:00

  • gamma-L-Glutaminyl-4-hydroxybenzene, an inducer of cryptobiosis in Agaricus bisporus and a source of specific metabolic inhibitors for melanogenic cells.

    abstract::A stable phenol, gamma-L-glutaminyl-4-hydroxybenzene (GHB), is oxidized by tyrosinase in the gill tissues of the mushroom Agaricus bisporus to a quinone and a second oxidation product which together suppress mitochondrial energy production and the synthesis of proteins and nucleic acids in the zygote, thus establishin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Vogel FS,Kemper LA,Jeffs PW,Cass MW,Graham DG

    更新日期:1977-04-01 00:00:00

  • Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo.

    abstract::The biological activity of two novel 14-epi-analogues of 1,25(OH)2D3, 19-nor-14-epi-23-yne-1,25(OH)2D3 (TX 522) and 19-nor-14,20-bisepi-23-yne-1,25(OH)2D3 (TX 527), is described. Both analogues were at least 10 times more potent than 1,25(OH)2D3 in inhibiting in vitro cell proliferation and had much lower in vivo calc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Verlinden L,Verstuyf A,Van Camp M,Marcelis S,Sabbe K,Zhao XY,De Clercq P,Vandewalle M,Bouillon R

    更新日期:2000-05-15 00:00:00

  • Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells.

    abstract::Diets enriched in n-3 polyunsaturated fatty acids (n-3 PUFA) may protect against breast cancer but biochemical mechanisms are unclear. Our studies showed that the n-3 fatty acid docosahexaenoic acid (DHA) up-regulated syndecan-1 (SDC-1) in human breast cancer cells, and we tested the hypothesis that DHA-mediated up-re...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-2305

    authors: Sun H,Berquin IM,Owens RT,O'Flaherty JT,Edwards IJ

    更新日期:2008-04-15 00:00:00

  • ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier.

    abstract::Delivery of therapeutic agents to the brain and its neoplasms depends on the presence of membrane transport proteins in the blood-brain barrier and in the target cells. The cellular and subcellular localization of these membrane transporters determines the drug accessibility to the brain and its tumors. We therefore a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1271

    authors: Bronger H,König J,Kopplow K,Steiner HH,Ahmadi R,Herold-Mende C,Keppler D,Nies AT

    更新日期:2005-12-15 00:00:00